Medicare Enrolled
Dr. Venkat Pavan Kancharla, M.D
Medical Oncology · Palm Bay, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kancharla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kancharla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kancharla
Dr. Venkat Pavan Kancharla is a medical oncology specialist in Palm Bay, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Kancharla performed 77,479 Medicare services across 2,058 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kancharla received a total of $72,125 from 114 pharmaceutical and/or device companies across 1749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kancharla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 28% volume in FL
$72,125 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 112590 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗77,479
Medicare services
Top 28% in FL for medical oncology
2,058
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,558 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nivolumab injection (Opdivo) | 14,600 | $24 | $81 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
14,400 | $0 | $7 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
13,920 | $2 | $21 |
| Pembrolizumab injection (Keytruda) | 13,800 | $43 | $146 |
| Denosumab injection (Prolia/Xgeva) | 5,880 | $18 | $70 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,550 | $0 | $3 |
| Iron infusion (Monoferric) | 2,800 | $17 | $74 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,810 | $1 | $122 |
| Anti-nausea injection (ondansetron/Zofran) | 932 | $0 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
811 | $64 | $180 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
633 | $8 | $35 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
489 | $22 | $152 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
483 | $96 | $686 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
408 | $89 | $879 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
380 | $8 | $19 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
302 | $2 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
285 | $11 | $93 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
260 | $48 | $304 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
239 | $97 | $224 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
184 | $12 | $105 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
179 | $2 | $19 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
167 | $49 | $334 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
139 | $1 | $7 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
124 | $21 | $156 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
118 | $124 | $420 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
98 | $16 | $97 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
73 | $25 | $249 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $24 | $90 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
69 | $1 | $19 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
58 | $64 | $157 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
47 | $15 | $111 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
38 | $10 | $73 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $26 | $141 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
34 | $106 | $297 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
29 | $3 | $15 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $140 | $420 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $84 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.0% high complexity
90.9% medium
3.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$72,125
Total received (2018-2024)
Avg $10,304/year across 7 years
Top 11% in FL for medical oncology
114
Companies
1,749
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$49,092 (68.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,402 (25.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,223 (4.5%)
Other
Charitable contributions, space rental, and other categories
$1,408 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,184
2023
$9,492
2022
$10,107
2021
$8,765
2020
$6,392
2019
$12,390
2018
$10,795
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$8,086
Bayer HealthCare Pharmaceuticals Inc.
$6,340
Novartis Pharmaceuticals Corporation
$5,555
Janssen Biotech, Inc.
$4,792
AstraZeneca Pharmaceuticals LP
$4,116
E.R. Squibb & Sons, L.L.C.
$3,990
Karyopharm Therapeutics Inc.
$3,037
BeiGene USA, Inc.
$2,836
PFIZER INC.
$2,142
Incyte Corporation
$2,127
Genentech USA, Inc.
$2,124
Seagen Inc.
$1,722
GENZYME CORPORATION
$1,491
Celgene Corporation
$1,388
Merck Sharp & Dohme LLC
$1,378
Takeda Pharmaceuticals U.S.A., Inc.
$1,148
Lilly USA, LLC
$1,119
Daiichi Sankyo Inc.
$1,054
GlaxoSmithKline, LLC.
$1,027
Merck Sharp & Dohme Corporation
$866
Astellas Pharma US Inc
$860
Regeneron Healthcare Solutions, Inc.
$839
Kite Pharma, Inc.
$755
Roche Products Limited
$710
Eisai Inc.
$695
EMD Serono, Inc.
$621
Pharmacyclics LLC, An AbbVie Company
$571
ABBVIE INC.
$478
Blueprint Medicines Corporation
$407
Ipsen Biopharmaceuticals, Inc
$375
Mirati Therapeutics, Inc.
$345
G1 Therapeutics, Inc.
$340
Exelixis Inc.
$339
Gilead Sciences, Inc.
$333
Pharmacosmos Therapeutics Inc.
$331
Puma Biotechnology, Inc.
$329
JAZZ PHARMACEUTICALS INC.
$326
Genmab U.S., Inc.
$307
Novocure Inc.
$277
PUMA BIOTECHNOLOGY, INC.
$275
EISAI INC.
$240
Janssen Scientific Affairs, LLC
$239
Boehringer Ingelheim Pharmaceuticals, Inc.
$233
TAIHO ONCOLOGY, INC.
$218
Taiho Oncology, Inc.
$205
Alexion Pharmaceuticals, Inc.
$192
TESARO, Inc.
$187
ARRAY BIOPHARMA INC
$187
SOBI, INC
$182
Dova Pharmaceuticals
$168
AbbVie, Inc.
$163
SERVIER PHARMACEUTICALS LLC
$163
Janssen Products, LP
$160
Bayer Healthcare Pharmaceuticals Inc.
$156
Myovant Sciences Inc.
$150
Coherus Biosciences Inc.
$145
MorphoSys, US Inc.
$140
SpringWorks Therapeutics, Inc.
$133
ADC Therapeutics America, Inc.
$133
Stemline Therapeutics Inc.
$132
HARMONY BIOSCIENCES LLC
$125
Boston Scientific Corporation
$125
RECORDATI_RARE_DISEASES_INC.
$124
Immunomedics, Inc.
$124
Pharmacyclics LLC, an AbbVie Company
$119
Sunovion Pharmaceuticals Inc.
$117
Heron Therapeutics, Inc.
$108
Geron Corporation
$102
Genentech, Inc.
$93
Rigel Pharmaceuticals, Inc.
$90
Helsinn Therapeutics (U.S.), Inc.
$86
Global Blood Therapeutics, Inc.
$85
Clovis Oncology, Inc.
$81
Dendreon Pharmaceuticals LLC
$75
AbbVie Inc.
$70
Nevro Corp.
$63
Agios Pharmaceuticals, Inc.
$62
TerSera Therapeutics LLC
$56
PharmaEssentia USA Corporation
$56
Seattle Genetics, Inc.
$55
Legend Biotech USA Inc.
$55
Deciphera Pharmaceuticals Inc.
$54
Mylan Institutional Inc.
$47
Verastem, Inc.
$44
Sumitomo Pharma America, Inc.
$43
AMAG Pharmaceuticals, Inc.
$43
Kyowa Kirin, Inc.
$41
Janssen Pharmaceuticals, Inc
$35
NESTLE HEALTHCARE NUTRITION INC.
$35
Nestle HealthCare Nutrition Inc.
$34
Alnylam Pharmaceuticals Inc.
$33
Secura Bio, Inc.
$33
Octapharma USA, Inc.
$30
Verity Pharmaceuticals Inc.
$28
Acceleron Pharma, Inc.
$28
Apellis Pharmaceuticals, Inc.
$25
Adaptive Biotechnologies Corporation
$25
Emmaus Medical, Inc.
$24
Sun Pharmaceutical Industries Inc.
$24
TG THERAPEUTICS, INC.
$24
AVEO Pharmaceuticals, Inc.
$22
Sobi, Inc
$20
Servier Pharmaceuticals LLC
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Medtronic, Inc.
$19
EUSA Pharma (US) LLC
$18
CTI BioPharma Corp.
$18
Advanced Accelerator Applications
$18
Epizyme, Inc.,
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$14
PORTOLA PHARMACEUTICALS, LLC
$13
Myriad Genetic Laboratories, Inc.
$12
Organon LLC
$10
Fortovia Therapeutics, Inc.
$10
Top 3 companies account for 27.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALDURAZYME · ALIMTA · ALUNBRIG · ANDEXXA · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cinvanti · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FASENRA · FERAHEME · FOTIVDA · FRUZAQLA · FULPHILA · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONHALA MAGNAIR · LONSURF · LOQTORZI · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRBETRIQ · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Ogivri · Omnia · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYTELO · Reblozyl · Reveal LINQ · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · Senza · Soltamox · Stivarga · Sylvant · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tecentriq Hybreza · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · WAKIX · WATCHMAN · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZYKADIA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $93 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
6
Per 100K population
1.0
County median income
$75,817
Nearest hospital
PALM BAY HOSPITAL
8.5 mi
8.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kancharla is a mixed practice specialist, with above-average Medicare volume (top 28% in FL), with low-engagement industry engagement in the top 11% of FL peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kancharla experienced with nivolumab injection (opdivo)?
Based on Medicare claims data, Dr. Kancharla performed 14,600 nivolumab injection (opdivo) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kancharla receive payments from pharmaceutical companies?
Yes. Dr. Kancharla received a total of $72,125 from 114 companies across 1,749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kancharla's costs compare to other medical oncologists in Palm Bay?
Dr. Kancharla's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kancharla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Palm Bay
Browse medical oncologists in Palm Bay ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology